BMO steps to sidelines on Regeneron

Shares of Regeneron (REGN -4.4%) are pulling back after a big run Tuesday.

BMO has downgraded the stock to Market Perform from Outperform.

Price target is unchanged at $331.

See also: Roth upbeat on REGN amid new Bayer deal, genetics initiative

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs